TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry | #o | #f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
4/17/24 12:04 | 4/17/24 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | 4 | 4 | P | 662 | 12.49 | 0 | 53 | 27 | 250 | D | ||||||||||||||
4/15/24 19:21 | 4/11/24 | OCX | Oncocyte Corp | CA | Health | Diagn | In Vitro & In Vivo Diagnostic | 3 | 3 | P.d | 7,168 | 2.92 | 0 | 2,457 | 33 | 9,946 | D | ||||||||||||||
3/8/24 11:24 | 3/6/24 | CATX | Perspective Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | 1 | 1 | P | 57,409 | 0.9500 | 0 | 60,431 | 107 | 116,773 | D | ||||||||||||||
3/6/24 16:49 | 3/4/24 | ACHV | Achieve Life Sciences, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | 2 | 2 | P.d | 92 | 4.59 | 0 | 20 | 21 | 115 | D | ||||||||||||||
2/27/24 16:21 | 8/15/22 | TKNO | Alpha Teknova, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | 1 | 1 | P.m | 50 | 5.37 | 0 | 9 | 9 | D | |||||||||||||||
2/26/24 18:48 | 2/23/24 | QDEL | Quidelortho Corp | Health | Diagn | In Vitro & In Vivo Diagnostic | 1 | 1 | P | 100 | 46.35 | 0 | 2 | 54 | 6 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |